{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["INTRODUCTION"], "sentence": "INTRODUCTION", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["Chronic", "myeloid", "leukemia", "(", "CML", ")", "is", "a", "clonal", "myeloproliferative", "disorder", "with", "a", "typical", "three", "phased", "course", "(", "chronic", ",", "accelerated", "and", "blastic", "phase", ")", "reflecting", "the", "loss", "of", "differentiation", "and", "malignant", "progress", "which", "inevitably", "leads", "to", "death", "after", "the", "blastic", "phase", "(", "1", ",", "2", ")", "."], "sentence": "Chronic myeloid leukemia ( CML ) is a clonal myeloproliferative disorder with a typical three phased course ( chronic , accelerated and blastic phase ) reflecting the loss of differentiation and malignant progress which inevitably leads to death after the blastic phase ( 1 , 2 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S3", "tokens": ["The", "hallmark", "genetic", "aberration", "of", "CML", "is", "a", "reciprocal", "chromosomal", "translocation", "t", "(", "9", ";", "22", ")", "leading", "to", "expression", "of", "a", "bcr-abl", "fusion", "gene", ",", "an", "aberrant", "activated", "tyrosine", "kinase", "(", "2", ")", "."], "sentence": "The hallmark genetic aberration of CML is a reciprocal chromosomal translocation t ( 9 ; 22 ) leading to expression of a bcr-abl fusion gene , an aberrant activated tyrosine kinase ( 2 ) .", "event_mentions": [{"id": "E1", "event_type": "Positive_regulation", "trigger": {"text": "leading", "start": 17, "end": 17}, "arguments": [{"entity_id": "T33", "text": "expression", "role": "Theme"}]}, {"id": "E2", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 19, "end": 19}, "arguments": [{"entity_id": "T1", "text": "bcr-abl fusion gene", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "bcr-abl fusion gene", "entity_type": "Protein", "start": 22, "end": 24}, {"id": "T32", "text": "leading", "entity_type": "Positive_regulation", "start": 17, "end": 17}, {"id": "T33", "text": "expression", "entity_type": "Gene_expression", "start": 19, "end": 19}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S4", "tokens": ["Treatment", "with", "interferon", "alpha", "(", "IFN-alpha", ")", "prolongs", "survival", "of", "CML", "patients", "and", "is", "associated", "with", "a", "complete", "cytogenetic", "response", "in", "5-33", "%", "of", "CML", "patients", "(", "1", ",", "2", ")", "."], "sentence": "Treatment with interferon alpha ( IFN-alpha ) prolongs survival of CML patients and is associated with a complete cytogenetic response in 5-33 % of CML patients ( 1 , 2 ) .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "interferon alpha", "entity_type": "Protein", "start": 2, "end": 3}, {"id": "T3", "text": "IFN-alpha", "entity_type": "Protein", "start": 5, "end": 5}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S5", "tokens": ["Recently", ",", "we", "described", "an", "impaired", "expression", "of", "the", "interferon", "regulatory", "factor", "4", "(", "IRF-4", ")", "in", "CML", ",", "correlating", "with", "poor", "response", "to", "IFN-alpha", "treatment", "(", "3", ")", "."], "sentence": "Recently , we described an impaired expression of the interferon regulatory factor 4 ( IRF-4 ) in CML , correlating with poor response to IFN-alpha treatment ( 3 ) .", "event_mentions": [{"id": "E3", "event_type": "Negative_regulation", "trigger": {"text": "impaired", "start": 5, "end": 5}, "arguments": [{"entity_id": "T35", "text": "expression", "role": "Theme"}]}, {"id": "E4", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 6, "end": 6}, "arguments": [{"entity_id": "T4", "text": "interferon regulatory factor 4", "role": "Theme"}]}], "entity_mentions": [{"id": "T4", "text": "interferon regulatory factor 4", "entity_type": "Protein", "start": 9, "end": 12}, {"id": "T5", "text": "IRF-4", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T6", "text": "IFN-alpha", "entity_type": "Protein", "start": 24, "end": 24}, {"id": "T34", "text": "impaired", "entity_type": "Negative_regulation", "start": 5, "end": 5}, {"id": "T35", "text": "expression", "entity_type": "Gene_expression", "start": 6, "end": 6}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S6", "tokens": ["The", "cause", "of", "the", "silencing", "of", "IRF-4", "level", "remained", "unclear", "."], "sentence": "The cause of the silencing of IRF-4 level remained unclear .", "event_mentions": [{"id": "E5", "event_type": "Negative_regulation", "trigger": {"text": "silencing", "start": 4, "end": 4}, "arguments": [{"entity_id": "T7", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T7", "text": "IRF-4", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T36", "text": "silencing", "entity_type": "Negative_regulation", "start": 4, "end": 4}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["Interferon", "regulatory", "factors", "(", "IRFs", ")", "are", "a", "family", "of", "transcriptional", "regulators", "defined", "by", "a", "characteristic", "homology", "in", "their", "DNA", "-", "binding", "domain", "."], "sentence": "Interferon regulatory factors ( IRFs ) are a family of transcriptional regulators defined by a characteristic homology in their DNA - binding domain .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["They", "play", "an", "important", "role", "in", "the", "regulation", "of", "various", "genes", "(", "such", "as", "IFNs", ",", "interleukins", ",", "MHC", "class", "I", "/", "II", ")", ",", "apoptosis", "and", "differentiation", "/", "maturation", "(", "4-6", ")", "."], "sentence": "They play an important role in the regulation of various genes ( such as IFNs , interleukins , MHC class I / II ) , apoptosis and differentiation / maturation ( 4-6 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S9", "tokens": ["IRF-4", "(", "ICSAT", "/", "Pip", "/", "MUM1", "/", "LSIRF", ")", "is", "one", "member", "with", "very", "restricted", "expression", "pattern", ":", "Predominately", "B", "-", "and", "activated", "T-lymphocytes", "are", "IRF-4", "positive", "(", "7-11", ")", "."], "sentence": "IRF-4 ( ICSAT / Pip / MUM1 / LSIRF ) is one member with very restricted expression pattern : Predominately B - and activated T-lymphocytes are IRF-4 positive ( 7-11 ) .", "event_mentions": [{"id": "E6", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 16, "end": 16}, "arguments": [{"entity_id": "T8", "text": "IRF-4", "role": "Theme"}]}, {"id": "E7", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 27, "end": 27}, "arguments": [{"entity_id": "T13", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T8", "text": "IRF-4", "entity_type": "Protein", "start": 0, "end": 0}, {"id": "T9", "text": "ICSAT", "entity_type": "Protein", "start": 2, "end": 2}, {"id": "T10", "text": "Pip", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T11", "text": "MUM1", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T12", "text": "LSIRF", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T13", "text": "IRF-4", "entity_type": "Protein", "start": 26, "end": 26}, {"id": "T37", "text": "expression", "entity_type": "Gene_expression", "start": 16, "end": 16}, {"id": "T38", "text": "positive", "entity_type": "Gene_expression", "start": 27, "end": 27}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S10", "tokens": ["In", "contrast", "to", "other", "IRFs", ",", "expression", "of", "IRF-4", "can", "not", "be", "induced", "by", "IFNs", ",", "but", "by", "antigen", "stimulation", ",", "crosslinking", "of", "T", "-", "or", "B-cell", "receptors", "or", "phorbol-myristate-acetate", "(", "10", ",", "11", ")", "."], "sentence": "In contrast to other IRFs , expression of IRF-4 can not be induced by IFNs , but by antigen stimulation , crosslinking of T - or B-cell receptors or phorbol-myristate-acetate ( 10 , 11 ) .", "event_mentions": [{"id": "E8", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 6, "end": 6}, "arguments": [{"entity_id": "T14", "text": "IRF-4", "role": "Theme"}]}, {"id": "E9", "event_type": "Positive_regulation", "trigger": {"text": "induced", "start": 12, "end": 12}, "arguments": [{"entity_id": "T39", "text": "expression", "role": "Theme"}]}], "entity_mentions": [{"id": "T14", "text": "IRF-4", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T39", "text": "expression", "entity_type": "Gene_expression", "start": 6, "end": 6}, {"id": "T40", "text": "induced", "entity_type": "Positive_regulation", "start": 12, "end": 12}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S11", "tokens": ["Consistent", "with", "the", "restriction", "of", "expression", "to", "immunocompetent", "cells", ",", "mice", "with", "deletion", "of", "IRF-4", "failed", "to", "develop", "mature", "and", "functionally", "active", "B", "-", "and", "T-lymphocytes", "(", "12", ")", ",", "and", "the", "impaired", "expression", "of", "IRF-4", "in", "CML", "was", "predominately", "found", "in", "T-cells", "(", "3", ")", "."], "sentence": "Consistent with the restriction of expression to immunocompetent cells , mice with deletion of IRF-4 failed to develop mature and functionally active B - and T-lymphocytes ( 12 ) , and the impaired expression of IRF-4 in CML was predominately found in T-cells ( 3 ) .", "event_mentions": [{"id": "E10", "event_type": "Negative_regulation", "trigger": {"text": "deletion", "start": 12, "end": 12}, "arguments": [{"entity_id": "T15", "text": "IRF-4", "role": "Theme"}]}, {"id": "E11", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 33, "end": 33}, "arguments": [{"entity_id": "T16", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T15", "text": "IRF-4", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T16", "text": "IRF-4", "entity_type": "Protein", "start": 35, "end": 35}, {"id": "T41", "text": "deletion", "entity_type": "Negative_regulation", "start": 12, "end": 12}, {"id": "T42", "text": "expression", "entity_type": "Gene_expression", "start": 33, "end": 33}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S12", "tokens": ["These", "data", "suggest", "a", "crucial", "role", "for", "IRF-4", "in", "the", "function", "of", "immune", "cells", "."], "sentence": "These data suggest a crucial role for IRF-4 in the function of immune cells .", "event_mentions": [], "entity_mentions": [{"id": "T17", "text": "IRF-4", "entity_type": "Protein", "start": 7, "end": 7}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["Methylation", "of", "dinucleotide", "cytosine-guanosine", "motifs", "(", "CpG", ")", ",", "especially", "in", "CpG", "islands", "located", "in", "promoter", "regions", ",", "is", "one", "of", "the", "mechanisms", "of", "gene", "regulation", "in", "mammals", "and", "a", "common", "event", "of", "gene", "silencing", "in", "human", "neoplasias", "(", "13", ",", "14", ")", "."], "sentence": "Methylation of dinucleotide cytosine-guanosine motifs ( CpG ) , especially in CpG islands located in promoter regions , is one of the mechanisms of gene regulation in mammals and a common event of gene silencing in human neoplasias ( 13 , 14 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["As", "opposed", "to", "normal", "cells", ",", "hypermethylation", "of", "CpG", "islands", "is", "a", "frequently", "observed", "phenomenon", "in", "every", "cancer", "type", "."], "sentence": "As opposed to normal cells , hypermethylation of CpG islands is a frequently observed phenomenon in every cancer type .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["De", "novo", "DNA", "methylation", "of", "genes", "such", "as", "cell", "cycle", ",", "DNA", "repair", ",", "apoptosis", "and", "tumor", "suppressor", "genes", "is", "therefore", "thought", "to", "be", "involved", "in", "tumorigenesis", "(", "15-17", ")", "."], "sentence": "De novo DNA methylation of genes such as cell cycle , DNA repair , apoptosis and tumor suppressor genes is therefore thought to be involved in tumorigenesis ( 15-17 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S16", "tokens": ["Examples", "for", "such", "aberrated", "genes", "are", "MGMT", ",", "DAPK", ",", "p14ARF", ",", "p15INK4b", ",", "p16INK4a", ",", "BRCA1", ",", "CDH13", "and", "APAF-1", "(", "17-19", ")", "."], "sentence": "Examples for such aberrated genes are MGMT , DAPK , p14ARF , p15INK4b , p16INK4a , BRCA1 , CDH13 and APAF-1 ( 17-19 ) .", "event_mentions": [], "entity_mentions": [{"id": "T18", "text": "MGMT", "entity_type": "Protein", "start": 6, "end": 6}, {"id": "T19", "text": "DAPK", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T20", "text": "p14ARF", "entity_type": "Protein", "start": 10, "end": 10}, {"id": "T21", "text": "p15INK4b", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T22", "text": "p16INK4a", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T23", "text": "BRCA1", "entity_type": "Protein", "start": 16, "end": 16}, {"id": "T24", "text": "CDH13", "entity_type": "Protein", "start": 18, "end": 18}, {"id": "T25", "text": "APAF-1", "entity_type": "Protein", "start": 20, "end": 20}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S17", "tokens": ["In", "CML", ",", "methylation", "is", "known", "to", "regulate", "expression", "of", "the", "c-abl", ",", "the", "bcr", "gene", "and", "others", "(", "20-23", ")", ",", "and", "the", "extent", "of", "methylation", "in", "the", "c-abl", "promoter", "has", "been", "shown", "to", "be", "associated", "with", "advanced", "disease", "(", "24", ")", "."], "sentence": "In CML , methylation is known to regulate expression of the c-abl , the bcr gene and others ( 20-23 ) , and the extent of methylation in the c-abl promoter has been shown to be associated with advanced disease ( 24 ) .", "event_mentions": [{"id": "E12", "event_type": "Regulation", "trigger": {"text": "regulate", "start": 7, "end": 7}, "arguments": [{"entity_id": "T44", "text": "expression", "role": "Theme"}]}, {"id": "E14", "event_type": "Regulation", "trigger": {"text": "regulate", "start": 7, "end": 7}, "arguments": [{"entity_id": "T44", "text": "expression", "role": "Theme"}]}, {"id": "E13", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 8, "end": 8}, "arguments": [{"entity_id": "T26", "text": "c-abl", "role": "Theme"}]}, {"id": "E15", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 8, "end": 8}, "arguments": [{"entity_id": "T27", "text": "bcr", "role": "Theme"}]}], "entity_mentions": [{"id": "T26", "text": "c-abl", "entity_type": "Protein", "start": 11, "end": 11}, {"id": "T27", "text": "bcr", "entity_type": "Protein", "start": 14, "end": 14}, {"id": "T28", "text": "c-abl", "entity_type": "Protein", "start": 29, "end": 29}, {"id": "T43", "text": "regulate", "entity_type": "Regulation", "start": 7, "end": 7}, {"id": "T44", "text": "expression", "entity_type": "Gene_expression", "start": 8, "end": 8}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["Hypermethylation", "due", "to", "overexpression", "of", "DNA", "methyltransferases", "(", "DNMTs", ")", "remains", "one", "possible", "explanation", "for", "de", "novo", "methylation", "in", "tumorigenesis", "."], "sentence": "Hypermethylation due to overexpression of DNA methyltransferases ( DNMTs ) remains one possible explanation for de novo methylation in tumorigenesis .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["Recently", ",", "DNMTs", "have", "been", "shown", "to", "be", "up-regulated", "in", "hematopoietic", "malignancies", "(", "25", ")", "."], "sentence": "Recently , DNMTs have been shown to be up-regulated in hematopoietic malignancies ( 25 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "", "tokens": ["Methyl-CpG", "-", "binding", "proteins", "(", "MBPs", ")", "are", "thought", "to", "inhibit", "the", "binding", "of", "transcriptional", "factors", "to", "the", "promoter", "and", "are", "therefore", "discussed", "as", "one", "mechanism", "of", "transcription", "inhibition", "by", "hypermethylation", "(", "26", ")", "."], "sentence": "Methyl-CpG - binding proteins ( MBPs ) are thought to inhibit the binding of transcriptional factors to the promoter and are therefore discussed as one mechanism of transcription inhibition by hypermethylation ( 26 ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S21", "tokens": ["In", "this", "work", ",", "we", "studied", "mechanisms", "of", "IRF-4", "gene", "expression", "silencing", "in", "leukemic", "cells", "."], "sentence": "In this work , we studied mechanisms of IRF-4 gene expression silencing in leukemic cells .", "event_mentions": [{"id": "E16", "event_type": "Gene_expression", "trigger": {"text": "expression", "start": 10, "end": 10}, "arguments": [{"entity_id": "T29", "text": "IRF-4", "role": "Theme"}]}, {"id": "E17", "event_type": "Negative_regulation", "trigger": {"text": "silencing", "start": 11, "end": 11}, "arguments": [{"entity_id": "T45", "text": "expression", "role": "Theme"}]}], "entity_mentions": [{"id": "T29", "text": "IRF-4", "entity_type": "Protein", "start": 8, "end": 8}, {"id": "T45", "text": "expression", "entity_type": "Gene_expression", "start": 10, "end": 10}, {"id": "T46", "text": "silencing", "entity_type": "Negative_regulation", "start": 11, "end": 11}]}
{"doc_id": "PMC-1310901-01-INTRODUCTION.txt", "sent_id": "S22", "tokens": ["We", "analyzed", "the", "IRF-4", "promoter", "region", "for", "genetic", "aberrations", "and", "methylational", "status", "in", "IRF-4", "-", "positive", "and", "-", "negative", "hematopoietic", "cells", "."], "sentence": "We analyzed the IRF-4 promoter region for genetic aberrations and methylational status in IRF-4 - positive and - negative hematopoietic cells .", "event_mentions": [{"id": "E18", "event_type": "Gene_expression", "trigger": {"text": "positive", "start": 15, "end": 15}, "arguments": [{"entity_id": "T31", "text": "IRF-4", "role": "Theme"}]}, {"id": "E19", "event_type": "Gene_expression", "trigger": {"text": "negative", "start": 18, "end": 18}, "arguments": [{"entity_id": "T31", "text": "IRF-4", "role": "Theme"}]}], "entity_mentions": [{"id": "T30", "text": "IRF-4", "entity_type": "Protein", "start": 3, "end": 3}, {"id": "T31", "text": "IRF-4", "entity_type": "Protein", "start": 13, "end": 13}, {"id": "T47", "text": "positive", "entity_type": "Gene_expression", "start": 15, "end": 15}, {"id": "T48", "text": "negative", "entity_type": "Gene_expression", "start": 18, "end": 18}]}
